It has been reported that low levels of TNF-α may promote SLE in predisposed mice and that the treatment of (NZB/NZW) F1 mice with TNF-α ameliorates nephritis [18], and low TNF-α expression may be implicated also in human SLE patients [19]. The gene discussed is TNF; the disease is systemic lupus erythematosus.